BRENNEN

Industries / Health / Healthcare / Medical spas

Body contouring

This work shrinks small pockets of fat, firms loose skin or tones muscle from outside the body, using cold, heat, focused sound waves, magnetic pulses or an injected drug instead of surgery.

7

Milestones achieved, from 2008 to 2017.

2

To watch for: announced, not yet confirmed outside.

2

Open deliverables. Nobody has shipped them.

The road

AchievedWatch forOpen

Achieved

  1. 2008

    Freezing fat, sparing skin

    In 1970 E. H. Epstein and M. E. Oren described "popsicle panniculitis": a red, firm lump and short-lived death of fat in the cheek of an infant who had been sucking an ice pop, a sign that fat is hurt by cold more easily than the skin over it. In 2008 Dieter Manstein, R. Rox Anderson and colleagues cooled the skin of anesthetized pigs to between −1 °C and −7 °C for 10 minutes. Several millimeters of fat were lost over three and a half months, with no visible injury to the skin, no scarring and no significant rise in blood fats.

    ebi.ac.ukpmc.ncbi.nlm.nih.gov

    Credit

    Dieter Manstein, R. Rox Anderson and colleagues; E. H. Epstein and M. E. Oren for the observation

  2. 2009

    Sound waves lift a brow

    On 11 September 2009 the FDA classified Ulthera's system, which focuses ultrasound beneath the skin to heat it, as a new type of device indicated "to lift the eyebrow". It used its de novo route, meant for devices with nothing already on the market to compare against. It was a lift without a cut; the FDA now lists focused ultrasound for heating tissue as a product type of its own.

    accessdata.fda.govfda.gov

    Credit

    Ulthera, Inc

  3. 2010

    Fat freezing cleared

    On 24 August 2010 the FDA granted Zeltiq Aesthetics a de novo classification for its Dermal Cooling Device, later sold as CoolSculpting, to reduce the fat layer under the skin and "affect the appearance of flanks (love handles)", on prescription. A 2025 meta-analysis of 30 studies with 3,158 participants, which had no funding, found abdominal circumference down 3.56 centimeters 12 weeks after treatment, but no significant change in thigh circumference or thigh fat thickness. Its first author offers CoolSculpting in his own clinics.

    accessdata.fda.govpmc.ncbi.nlm.nih.gov

    Credit

    Zeltiq Aesthetics

  4. 2010

    Fat-melting shots warned off

    On 7 April 2010 the FDA sent warning letters to six US medical spas and a company in Brazil for false or misleading claims about "lipodissolve", a series of injections meant to dissolve small pockets of fat, usually phosphatidylcholine and deoxycholate. The agency said it knew of no credible evidence that the drugs remove fat, and that it had reports of permanent scarring, skin deformation and deep painful knots.

    LessonDeoxycholic acid came back five years later as an approved drug, once placebo-controlled trials had measured what it does.

    news-medical.netnpr.org

    Credit

    US Food and Drug Administration

  5. 2014

    Frozen fat that grows

    H. Ray Jalian, Mathew Avram, R. Rox Anderson and colleagues described paradoxical adipose hyperplasia: an area treated by fat freezing that slowly grows larger, as a firm mass of fat, starting months later. They put it at 0.0051%, about 1 in 20,000 treatments. Later counts are higher. A 2021 review of 8,658 treatment cycles in 2,114 patients at several clinics found 0.05% to 0.39% per cycle, against the maker's quoted 0.025%, and a 2025 meta-analysis of 28 studies and 13,078 patients put it at 0.22%, about 1 in 455 patients, on low-certainty evidence.

    LessonThe first rate for a rare harm came from early counts and was too low.

    ebi.ac.ukebi.ac.uk

    Credit

    H. Ray Jalian and colleagues

  6. 2015

    A drug for chin fat

    On 29 April 2015 the FDA approved Kybella from Kythera Biopharmaceuticals, an injectable form of deoxycholic acid, as a new molecular entity for moderate to severe fullness under the chin. In the REFINE-1 trial, 70.0% of 256 treated adults improved by at least one grade on both the doctor's and the patient's scale, against 18.6% of 250 given a placebo. In 4.3% of treated people the nerve that moves the lower lip was briefly weakened.

    accessdata.fda.govebi.ac.uk

    Credit

    Kythera Biopharmaceuticals

  7. 2017

    Magnets to firm muscle

    On 16 February 2017 the FDA cleared BTL Industries' AM-100, which makes a strong pulsing magnetic field that sets muscles contracting, for "improvement of abdominal tone" and for firming the buttocks and thighs. The clearance rested on equivalence to an earlier stimulator and on bench tests; the summary lists no clinical data. A 2025 review of the seven published studies of BTL's later Emsculpt Neo, which adds radiofrequency heating, found all seven written by BTL's medical advisers, photographs often not standardized, and measured changes likely within the margin of error.

    LessonA device cleared by comparison can carry a new cosmetic claim with no patient data behind it.

    fda.innolitics.comebi.ac.uk

    Credit

    BTL Industries

Watch for

  1. A second fat-dissolving drug

    Caliway Biopharmaceuticals says CBL-514, an injection that makes fat cells die off, reduces belly fat. In its randomized Phase 2b trial, published in May 2026, 76.7% of treated people in the analysis set (23 of 30) improved by at least one grade on a doctor's scale, against 18.9% (7 of 37) on placebo, and MRI showed fat volume down an average of 152.9 milliliters, or 20.3%. Two Phase 3 trials planned at 320 people each started in September 2026, at sites in the United States and Canada, and in November 2026.

    Achieved whenthe Phase 3 trials report and a regulator approves the drug.

    ebi.ac.ukclinicaltrials.govclinicaltrials.gov

    Claimed by

    Caliway Biopharmaceuticals, May 2026

  2. Muscle kept on weight-loss drugs

    Educational content funded by BTL Industries in American Family Physician in May 2026 presents its Emsculpt Neo as a way to counter the muscle that people lose along with fat on GLP-1 weight-loss drugs, citing an MRI study in which the treatment raised muscle mass by 25%. No trial in people taking these drugs was found in ClinicalTrials.gov among 6 Emsculpt and 30 HIFEM (high-intensity focused electromagnetic) studies.

    Achieved whena randomized, sham-controlled trial in people on GLP-1 drugs, not run by BTL advisers, shows lean mass or strength kept better than with a sham.

    aafp.orgclinicaltrials.gov

    Claimed by

    BTL Industries, May 2026

Open

  1. 01

    Body-contouring claims, checked

    A tool that reads clinic web pages advertising fat freezing, radiofrequency, focused ultrasound and magnetic muscle treatments, pulls out each claim (the body site, "FDA approved", weight loss, permanent results), and compares it with what the FDA cleared that device to do. It publishes the share of pages with claims outside the clearance, by device type, and repeats the count every quarter.

    The brief
    Credit · unclaimed
  2. 02

    Before-and-after photos, scored

    A tool that checks a published pair of before-and-after body photos for the differences that change how a body looks with no treatment at all: camera height and distance, lens, direction of light, posture and where the waistband sits. Each pair gets a consistency score.

    The brief
    Credit · unclaimed

Open 01 · the brief

Body-contouring claims, checked

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

A tool that reads clinic web pages advertising fat freezing, radiofrequency, focused ultrasound and magnetic muscle treatments, pulls out each claim (the body site, "FDA approved", weight loss, permanent results), and compares it with what the FDA cleared that device to do. It publishes the share of pages with claims outside the clearance, by device type, and repeats the count every quarter.

Why it is still open

The FDA says no non-invasive body-contouring device is cleared or approved to treat the breasts, and that such devices do not cause weight loss. A 2024 study by Diego Gomez and colleagues checked 100 practice websites for each of two aesthetic lasers by hand and found at least one off-label claim on 59 and 44 of them; it did not cover body-contouring devices or repeat the count. A 2026 Australian audit found 18% to 71% of cosmetic surgeons breaching new advertising rules, depending on their professional body, again by hand and in one state.

fda.govebi.ac.ukebi.ac.uk

Built with what exists

Playwright or Scrapy to collect pages; the openFDA 510(k) interface and the FDA's de novo orders for cleared indications; a small language model to pull out claims, such as Meta's Muse Ember (Notes: "The jobs agents repeat"), checked against a hand-labelled sample; Python and DuckDB.

  1. First step

    Collect 50 pages advertising fat freezing in one city and label their claims by hand against the cleared indications.

  2. Done looks like

    1,000 US clinic pages labelled; a sample of 300 on which the tool and two human reviewers agree on at least 90% of claims (the Australian audit's outside reviewer agreed with 95% of its calls); the share of pages with an off-label claim published by device type; and the count repeated a quarter later.

Open 02 · the brief

Before-and-after photos, scored

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

A tool that checks a published pair of before-and-after body photos for the differences that change how a body looks with no treatment at all: camera height and distance, lens, direction of light, posture and where the waistband sits. Each pair gets a consistency score.

Why it is still open

The 2025 review of the Emsculpt Neo studies found photographs often not standardized, with unexplained changes in untreated areas. Zenoti, a clinic software maker, says its photo manager checks angle, framing and lighting at the moment a clinic takes a photo, which helps the clinic but not a reader of its ads. A 2026 study ran an AI detector of digital editing on 600 rhinoplasty photos on RealSelf and flagged 19.5%, but it looks for altered pixels, not pose or lighting, and covers faces, not bodies. No tool was found that scores finished body photos in advertisements.

ebi.ac.ukzenoti.comebi.ac.uk

Built with what exists

Google's MediaPipe pose landmarker for body landmarks; OpenCV for scale, light direction and color temperature; image metadata where it survives; a vision-language model for clothing position; a store mannequin torso to build the test set, so no person is photographed for it.

  1. First step

    Photograph a mannequin torso under 10 controlled changes and check whether the pose landmarks shift measurably between pairs.

  2. Done looks like

    On 200 mannequin photo pairs with planted changes (camera 10 centimeters higher, 20 centimeters closer, light moved 45 degrees, a different lens), the tool flags at least 90% of the changes with no more than 10% false alarms. It then scores 500 pairs from clinic advertisements, three clinical photographers rate 100 of them on their own, and the agreement between them and the tool is published.